Phio Stock Based Compensation from 2010 to 2024
PHIO Stock | USD 0.79 0.06 8.22% |
Stock Based Compensation | First Reported 2012-03-31 | Previous Quarter 9 K | Current Value 9 K | Quarterly Volatility 204.1 K |
Check Phio Pharmaceuticals financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Phio main balance sheet or income statement drivers, such as Depreciation And Amortization of 115.8 K, Interest Expense of 211.3 K or Other Operating Expenses of 9 M, as well as many exotic indicators such as Price To Sales Ratio of 275, Dividend Yield of 0.0 or PTB Ratio of 0.19. Phio financial statements analysis is a perfect complement when working with Phio Pharmaceuticals Valuation or Volatility modules.
Phio | Stock Based Compensation |
Latest Phio Pharmaceuticals' Stock Based Compensation Growth Pattern
Below is the plot of the Stock Based Compensation of Phio Pharmaceuticals Corp over the last few years. It is compensation provided to employees in the form of equity or options to purchase company stock. This type of compensation is used to align the interests of employees and shareholders. Phio Pharmaceuticals' Stock Based Compensation historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Phio Pharmaceuticals' overall financial position and show how it may be relating to other accounts over time.
Stock Based Compensation | 10 Years Trend |
|
Stock Based Compensation |
Timeline |
Phio Stock Based Compensation Regression Statistics
Arithmetic Mean | 921,257 | |
Geometric Mean | 636,603 | |
Coefficient Of Variation | 83.16 | |
Mean Deviation | 669,128 | |
Median | 480,000 | |
Standard Deviation | 766,116 | |
Sample Variance | 586.9B | |
Range | 2M | |
R-Value | (0.84) | |
Mean Square Error | 183.2B | |
R-Squared | 0.71 | |
Significance | 0.00008 | |
Slope | (144,372) | |
Total Sum of Squares | 8.2T |
Phio Stock Based Compensation History
Other Fundumenentals of Phio Pharmaceuticals Corp
Phio Pharmaceuticals Stock Based Compensation component correlations
Click cells to compare fundamentals
About Phio Pharmaceuticals Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include Phio Pharmaceuticals income statement, its balance sheet, and the statement of cash flows. Phio Pharmaceuticals investors use historical funamental indicators, such as Phio Pharmaceuticals's Stock Based Compensation, to determine how well the company is positioned to perform in the future. Although Phio Pharmaceuticals investors may use each financial statement separately, they are all related. The changes in Phio Pharmaceuticals's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Phio Pharmaceuticals's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Phio Pharmaceuticals Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Phio Pharmaceuticals. Please read more on our technical analysis and fundamental analysis pages.
Last Reported | Projected for Next Year | ||
Stock Based Compensation | 303 K | 287.9 K | |
Stock Based Compensation To Revenue | 16.43 | 21.55 |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out the analysis of Phio Pharmaceuticals Correlation against competitors. You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .
Complementary Tools for Phio Stock analysis
When running Phio Pharmaceuticals' price analysis, check to measure Phio Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Phio Pharmaceuticals is operating at the current time. Most of Phio Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Phio Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Phio Pharmaceuticals' price. Additionally, you may evaluate how the addition of Phio Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios |
Is Phio Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Phio Pharmaceuticals. If investors know Phio will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Phio Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (5.20) | Return On Assets (0.60) | Return On Equity (1.17) |
The market value of Phio Pharmaceuticals Corp is measured differently than its book value, which is the value of Phio that is recorded on the company's balance sheet. Investors also form their own opinion of Phio Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Phio Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Phio Pharmaceuticals' market value can be influenced by many factors that don't directly affect Phio Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Phio Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Phio Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Phio Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.